EFDID: 103276EFD: View Filing

Issuer: Neurodyn Life Sciences Inc. (0001568852) - D

Accession: 0001140361-14-036469 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001568852
  • Entity Name:
    Neurodyn Life Sciences Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    439 Helmcken Street
    VANCOUVER, A1 V6B 2E6
  • Persons:
    Related Persons 6
    Kenneth A. Cawkell
    Executive Officer, Director
    Denis G. Kay
    Executive Officer, Director
    Robert L. Cervelli
    Director
    James Mertz
    Director
    Madolyn Mertz
    Director
    Richard Devries
    Director
EDGAR: Offering Information
  • Accession Date:
    09/25/2014
  • First Sale Date:
    01/07/2014
  • Offering Amount:
    $349,185
  • Amount Sold:
    $349,185
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Series A preferred and underlying common shares.
  • Sales Clarification:
    US$1.00=Cdn$1.0742.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Neurodyn Life Sciences Inc./s/ Kenneth A. CawkellKenneth A. CawkellChief Executive Officer2014-09-24